Richard A. Meier - May 12, 2023 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Director
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
May 12, 2023
Transactions value $
-$63
Form type
4
Date filed
5/17/2023, 06:14 PM
Previous filing
Oct 21, 2022
Next filing
May 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Options Exercise $576K +8.5K +7.8% $67.81 117K May 12, 2023 Direct
transaction BMRN Common Stock Tax liability -$576K -6.14K -5.22% $93.93 111K May 12, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to Buy Common Stock) Options Exercise $0 -8.5K -100% $0.00* 0 May 12, 2023 Common Stock 8.5K $67.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the number of options outstanding after the transactions from this specific stock option grant.